Research
Hormonal
Correcting hormonal deficiencies may improve exercise capacity and reduce major cardiac events.
Clinicians should consider hormonal assessments in patients at risk of cardiovascular events.
StrongSupportsmedium confidence
emerging data showing that correcting these imbalances can improve exercise capacity and possibly reduce major cardiac events.
Why this rating
The claim is supported by emerging data referenced in the abstract.
Source
Cardiovascular–Endocrine–Metabolic Medicine: Proposing a New Clinical Sub-Specialty Amid the Cardiometabolic Pandemic
Nikolaos Theodorakis et al. · Biomolecules · 2025
DOI 10.3390/biom15030373
otherCited 9×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →